Boston Scientific News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

12.05.10	Boston Scientific GIBT europäische zulassung des Platin-Chrom-Stentsystems TAXUS(R) Element(TM) bekannt (Newsaktuell)
15.03.10	Boston Scientific gibt bekannt, dass 1.000 Europäische patienten das LATITUDE(R) patient management system verwenden (Newsaktuell)
03.06.08	Boston Scientific Announces CEO Jim Tobin to Extend Tenure (PR Newswire)
28.05.08	Texas Jury Awards $250 Million Patent Infringement Verdict Against Boston Scientific in Balloon Catheter Lawsuit (PR Newswire)
16.05.08	Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R) (PR Newswire)
24.04.08	Boston Scientific to Participate in Morgan Stanley Conference (PR Newswire)
17.04.08	Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System (PR Newswire)
14.04.08	Boston Scientific Announces Japanese Approval of Heart Failure Lead (PR Newswire)
26.02.08	Boston Scientific Announces Addition to Clinical Sciences Organization (PR Newswire)
13.12.07	Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million (PR Newswire)
06.11.07	Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record (PR Newswire)
20.07.07	Boston Scientific Announces Results for Second Quarter Ended June 30, 2007 (PR Newswire)
28.06.07	Boston Scientific and CryoCor Announce Strategic Collaboration in Atrial Fibrillation (PR Newswire)
11.06.07	Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch (PR Newswire)
21.05.07	Stroke, Death, and TIA Rates Significantly Reduced With Closed-Cell Carotid Stents (PR Newswire)
20.03.07	Boston Scientific Announces Schedule for ACC 2007 (PR Newswire)
28.02.07	Boston Scientific Announces Launch of Race Against Pain(SM) Campaign to Shine Spotlight on Pain Management Technology (PR Newswire)
12.02.07	Boston Scientific Comments on Swedish Registry Results (PR Newswire)
16.01.07	Boston Scientific Comments on U.K. Court Decision on Angiotech Patent (PR Newswire)
07.12.06	Data Presented To FDA Panel Show TAXUS Drug-Eluting Stents as Safe as Bare-Metal Stents and Far More Effective in Reducing Repeat Procedures (PR Newswire)
14.11.06	Boston Scientific and University of Akron Expand License Agreement for Use of UA Polymers in Medical Devices (PR Newswire)
16.10.06	Boston Scientific Launches Clinical Trial to Study Endovascular Treatment of Brain Aneurysms (PR Newswire)
20.06.06	Study of Boston Scientific's Carotid WALLSTENT(TM) Monorail(TM) Design Shows Superior Safety Results in Stroke Prevention (PR Newswire)
11.05.06	Boston Scientific Announces Appointment of Donald Baim, M.D., as Chief Medical and Scientific Officer (PR Newswire)
10.05.06	Boston Scientific and BioForm Medical Announce FDA Approval of Coaptite(R) Injectable Implant (PR Newswire)
09.05.06	Boston Scientific to Release Latest Clinical Trial Results on Market-Leading TAXUS(R) Coronary Stent Systems at EuroPCR (PR Newswire)
29.03.06	ACC Data Show Numerical Trend Favoring TAXUS(R) Coronary Stent System (PR Newswire)
14.03.06	STENT Registry Safety Data Favors TAXUS(R) Over Cypher(R) in the Most Complex Diabetic Patients (PR Newswire)
12.03.06	STENT Registry Safety Data Favors TAXUS(R) Over Cypher(R) in the Most Complex Diabetic Patients (PR Newswire)
10.03.06	Boston Scientific Announces Leadership Team for New Cardiac Rhythm Management Group (PR Newswire)
07.03.06	Boston Scientific to Release Broad Range of Clinical Study Results on Market-Leading Taxus(R) Coronary Stent System at ACC 2006 (PR Newswire)
07.02.06	MORNING UPDATE: Seven Summits Research Issues Alerts for BSX, ATVI, OXY, YUM, and NBR (PR Newswire)
14.12.05	Boston Scientific Announces $500,000 Fellowship Grant to University of Minnesota Foundation (PR Newswire)
08.12.05	Boston Scientific Honored with American Red Cross Circle of Humanitarian Award (PR Newswire)
03.12.05	Boston Scientific Announces Worldwide Recall of Stainless Steel Greenfield(R) Vena Cava Filters Manufactured Before March 10, 2004 (PR Newswire)
10.11.05	Corautus Genetics Reports Third Quarter Results (PR Newswire)
18.10.05	Boston Scientific Study Shows Excellent Performance in High-Risk Patients with Carotid Artery Disease (PR Newswire)
10.10.05	Boston Scientific to Release Long-Term Clinical Trial Results on Market- Leading TAXUS(R) Express2(TM) Coronary Stent System at TCT 2005 (PR Newswire)
10.10.05	Boston Scientific to Release Long-Term Clinical Trial Results on Market- Leading TAXUS(R) Express2(TM) Coronary Stent System at TCT 2005 (PR Newswire)
31.08.05	Boston Scientific Announces Launch of Chilli II(TM) Cooled Ablation Catheter (PR Newswire)
02.08.05	14-Month-Old Twins Will Hear for the First Time with Initial Activation of Bilateral Cochlear Implants (PR Newswire)
19.07.05	MORNING UPDATE: brokersXpress, LLC Issues Alerts for IBM, NVDA, USB, MMM, and BSX (PR Newswire)
06.07.05	MORNING UPDATE: Mankus-Lavelle Group issues alerts for KRB, MERQ, BSX, RHAT, and CTXS (PR Newswire)
18.05.05	Four Clinical Studies Support Safety and Effectiveness of ENTERYX(R) Procedure in Treating GERD Symptoms (PR Newswire)
02.05.05	Corautus Genetics Inc. Names Michael K. Steele as Vice President - Bus (PR Newswire)
14.04.05	Boston Scientific and Rubicon Medical Announce CE Mark for the Rubicon (Businesswire)
14.04.05	Boston Scientific Corporation and Rubicon Medical Corporation Amend Ag (Businesswire)
12.04.05	Boston Scientific's Quincy Fulfillment Center Receives Prestigious Cus (PR Newswire)
04.03.05	MORNING UPDATE: Man Securities Inc. Issues Alerts for SONS, BSX, FOX, (PR Newswire)
04.03.05	MORNING UPDATE: Man Securities Inc. Issues Alerts for SONS, BSX, FOX, (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

10:02		DAX 40-Titel Fresenius SE-Aktie: So viel hätten Anleger an einem Fresenius SE-Investment von vor einem Jahr verdient
06:21		Erste Schätzungen: Fresenius SE legt Quartalsergebnis vor
21.04.25		DAX 40-Wert Fresenius Medical Care (FMC) St-Aktie: So viel Verlust hätte ein Investment in Fresenius Medical Care (FMC) St von vor 3 Jahren bedeutet
21.04.25		Erste Schätzungen: Fresenius Medical Care (FMC) St legt die Bilanz zum abgelaufenen Quartal vor
16.04.25		Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Verlust hätte ein Johnson Johnson-Investment von vor 3 Jahren eingebracht
15.04.25		Johnson & Johnson steigert in Q1 Umsatz und Gewinn - Aktie leichter
15.04.25		Ausblick: Johnson & Johnson gibt Ergebnis zum abgelaufenen Quartal bekannt
15.04.25		DAX 40-Wert Fresenius SE-Aktie: So viel Verlust hätte eine Investition in Fresenius SE von vor 10 Jahren bedeutet

10:02

DAX 40-Titel Fresenius SE-Aktie: So viel hätten Anleger an einem Fresenius SE-Investment von vor einem Jahr verdient

06:21

Erste Schätzungen: Fresenius SE legt Quartalsergebnis vor

21.04.25

DAX 40-Wert Fresenius Medical Care (FMC) St-Aktie: So viel Verlust hätte ein Investment in Fresenius Medical Care (FMC) St von vor 3 Jahren bedeutet

21.04.25

Erste Schätzungen: Fresenius Medical Care (FMC) St legt die Bilanz zum abgelaufenen Quartal vor

16.04.25

Dow Jones 30 Industrial-Papier Johnson Johnson-Aktie: So viel Verlust hätte ein Johnson Johnson-Investment von vor 3 Jahren eingebracht

15.04.25

Johnson & Johnson steigert in Q1 Umsatz und Gewinn - Aktie leichter

15.04.25

Ausblick: Johnson & Johnson gibt Ergebnis zum abgelaufenen Quartal bekannt

15.04.25

DAX 40-Wert Fresenius SE-Aktie: So viel Verlust hätte eine Investition in Fresenius SE von vor 10 Jahren bedeutet

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Lonza Grp	544.20	0.93 %	K V
Swiss Re	142.65	0.60 %	K V
Zurich Insur Gr	562.60	0.50 %	K V
Swiss Life Hldg	787.00	0.49 %	K V
CieFinRichemont	136.75	-0.11 %	K V
Nestle	85.70	-2.59 %	K V
Roche Hldg G	248.70	-2.70 %	K V
Part Grp Hldg	1’027.50	-2.88 %	K V
ABB	40.90	-3.08 %	K V
Geberit	532.40	-3.41 %	K V

Boston Scientific Aktie VALOR 913577 / ISIN US1011371077

Nachrichten zu Boston Scientific Corp.

Aktien Top/Flop

Boston Scientific Peer Group Nachrichten

Meistgelesene Nachrichten